Avillion announces positive high-level results from Phase III BATURA trial with AstraZeneca’s inhaled anti-inflammatory medication Airsupra in asthma patients London, UK, 7 October 2024 – Avillion Life Sciences Ltd (“Avillion”) announces that the ongoing BATURA Phase IIIb trial evaluating…
5 Large Drug Stocks to Watch From a Thriving Industry Drug and biotech companies are seeing significant innovation in 2024. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), AstraZeneca (AZN),…
AstraZenecas Calquence sNDA Gets FDA Priority Tag for Expanded Use The FDA grants priority review to AZNs sNDA for Calquence for untreated mantle cell lymphoma. A decision is expected in…
Total Voting Rights 1 October 2024 15:00 BST Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…